Clinical Trials Browser

Phase 2 × Unknown × Drug-Related Side Effects and Adverse Reactions × Clear all

NCT04635956 2020-11-19

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Phase 2 Unknown

Uterine Cervical Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04351308 2020-05-19

MAPAC

Phase 2 Unknown

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

Phase 2 Unknown

Drug-Related Side Effects and Adverse Reactions

NCT01965275 2017-05-08

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Phase 2 Unknown

Drug-Related Side Effects and Adverse Reactions

NCT02549911 2015-09-15

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02324803 2014-12-24

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Phase 2 Unknown

Carcinoma, Renal Cell, Drug-Related Side Effects and Adverse Reactions

NCT02024568 2013-12-31

Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia

Phase 2 Unknown

Myotoxicity, Agnosia, Breast Neoplasms, Pain, Drug-Related Side Effects and Adverse Reactions

NCT00003583 2013-12-04

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Phase 2 Unknown

Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions